Randomized Controlled Trial of Prenatal Coparenting Intervention for African American Fragile Families
Abstract
This R01 tests through RCT methodology efficacy of a new intervention designed specifically to aid development of positive coparenting alliances between at-risk (unmarried, uncoupled, low income) African American mothers and fathers having a first baby together.
Conditions: Parenting.
Primary outcome: System for Coding Interactions in Dyads (SCID) Positive Communication Patterns; System for Coding Interactions in Dyads (SCID) Negative Communication Patterns; System for Coding Interactions in Dyads (SCID) Positive Communication Patterns; System for Coding Interactions in Dyads (SCID) Negative Communication Patterns; Coparenting and Family Rating Scale (CFRS) Coparent Solidarity/Family Harmony; Coparenting and Family Rating Scale (CFRS) Coparent Negativity/Hostility & Competitiveness; Coparenting and Family Rating Scale (CFRS) Coparent Solidarity/Family Harmony; Coparenting and Family Rating Scale (CFRS) Coparent Negativity/Hostility & Competitiveness; Perceived Coparenting Solidarity as Measured by Parenting Alliance Measure (PAM) Communication Subscale; Perceived Coparenting Solidarity as Measured by Parenting Alliance Measure (PAM) Respect Subscale; Intimate Partner Violence as Assessed by the Psychological Aggression Scale of the Revised-Conflict Tactics Scale (CTS2; Straus et al., 1996).; Infant Socio-emotional Competencies as Assessed by the Negative Emotionality Scale of the Infant Toddler Social Emotional Assessment (ITSEA; Carter & Briggs-Gowan, 2006); Infant…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 276 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.